The Endocrine Club

Directions

The Endocrine Club General endocrinology and diabetes practical points
Chairman/admin :
Abdulqawi Almansari MBBS FACP FACE

Chairman Abdulqawi Almansari MD FACP FACE
Consultant endocrinologist
Myclinic alsafa Jeddah
American board of Endocrinology Diabetes and Metabolism2000
American Board internal Medicine 1998

18/10/2026

62 M history of ischemic stroke and CAD ( 3 stents ) . Compliant on antiplatelets therapy and Rousovastatin 20 mg. LDL 67 mg/dl
What is the next step ?

18/10/2026

Thyroid hormone treatment is NOT indicated in euthyroid individuals with nodular thyroid disease
2023 European Thyroid Association

17/10/2026

The 2025 ATA Guidelines revised TSH target in DTC
Initial Post-Operative TSH Targets
High-Risk : TSH < 0.1
Intermediate-Risk: TSH between 0.1- 0.5
Low-Risk : TSH 0.5- 2.0

17/10/2026

EASD 2026 highlight

Emerging evidence also highlighted the potential for amylin-based therapies to influence body composition and energy expenditure.

17/10/2026

EASD 2026 Highlight

Retatrutide produced substantial, dose-dependent, durable weight loss through 80 weeks, exceeding semaglutide and tirzepatide in indirect comparisons. Weight loss was accompanied by significant improvements in glycemic control, blood pressure, lipids, and inflammation

17/10/2026

57 M uncontrolled HTN on 3 medicatios ( ACE-I Amlodipine and Diuretic) 147/94 , Work up exluded secondery hypertension . not diabetic and no history of hear disease
What is the next step ?

16/10/2026

Adherence increases when patients with T2D switch from two oral glucose-lowering agents to an SPC ( Single Pill Combination
Clin Ther 2004;26:2066

16/10/2026

ACEL-UK study indicate that levothyroxine treatment is associated with lower cardiovascular mortality (30% reduction) and lower all-cause mortality (29% reduction) in older adults, contradicting the fear that treating mild hypothyroidism is largely harmful.
Thyroid Res. 2023 Nov

16/10/2026

EASD 2026 highlight

Chronic GLP-1 RA or SGLT2i treatment was associated with lower in-hospital
mortality among diabetic patients hospitalized for AHF

16/10/2026

Do not (routinely) offer self-monitoring of CBG for adults with DM2 unless:
-On insulin
-Evidence of hypoglycaemia
-On oral medication may increase their risk of hypoglycaemia
- Pregnant or are planning to become pregnant

NICE 2026

Address

Jeddah

Website

Alerts

Be the first to know and let us send you an email when The Endocrine Club posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share